VIE/MRK (VIE/MRK)

Vienna Stock Exchange: VIE/MRK · EUR

€126

-1.56 (-1.2%)· Recorded snapshot

Market cap	312B
Revenue (ttm)	58.3B
Net income (ttm)	2.8B
EPS (ttm)	€1.14
P/E (trailing)	110.3x
P/E (forward)	16.7x
Dividend	€2.94 (2.33%)
Beta	0.22

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 58.3B
Net income (ttm): 2.8B
EPS (ttm): €1.14
P/E (trailing): 110.3x
P/E (forward): 16.7x
Market cap: 312B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-29 13:30 UTC

Forward P/E16.7

P25 n/aP50 n/aP75 n/a

Trailing P/E110.3

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/MRK indicators

Market & fundamental data

Available fields

239

Groups with data

Currency

USD

Showing 239 of 239 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-29
Employees	75,000
Employees change	0
Employees growth	0%
Enterprise value	EUR 354B
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1891
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US58933Y1055
Last earnings date	2026-10-29
Last refreshed	2026-10-29
Market cap	EUR 312B
Next earnings date	2026-10-29
Price	EUR 126.04
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	vie/MRK
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	56.04x
Average P/E ratio (3Y)	100.29x
Average P/E ratio (5Y)	71.09x
Earnings yield	0.91%
EV/Earnings	127.45x
EV/EBIT	16.8x
EV/EBITDA	13.47x
EV/FCF	25.18x
EV/Sales	5.93x
FCF / EV yield	3.97%
FCF yield	4.51%
Forward P/E	16.73x
Graham number	19.36161
Graham upside	-84.64%
Lynch fair value	EUR 5.61
Lynch upside	-95.55%
P/(FCF - SBC) ratio	23.49x
P/(OCF - SBC) ratio	18.68x
P/B ratio	8.49x
P/E ratio	110.3x
P/FCF ratio	22.19x
P/OCF ratio	17.85x
P/S ratio	5.35x
Price/EBITDA ratio	12.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.28%
EBITDA margin	43.37%
Effective tax rate	46.72%
FCF margin	23.53%
Gross margin	75.9%
Operating margin	35.28%
Pretax margin	8.94%
Profit margin	4.77%
Profit per employee	EUR 37,531
Profitable years	35
Revenue per employee	EUR 787,403
ROA	11.87%
ROA (5Y)	11.18%
ROCE	23.01%
ROE	6.96%
ROE (5Y)	30.37%
ROIC	14.05%
ROIC (5Y)	22.36%
SBC / revenue	1.34%
Tax / revenue	4.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-80.37%
EPS growth 10Y	-3.53%
EPS growth 3Y	1.25%
EPS growth 5Y	-10.38%
EPS growth years	2
FCF growth	9.11%
FCF growth (Q)	77.03%
FCF growth (QoQ)	52.96%
FCF growth 3Y	14.05%
FCF growth 5Y	18.23%
Gross profit growth	2.6%
Gross profit growth (Q)	0.52%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	9.69%
Net income growth	-80.66%
Net income growth 3Y	0.66%
Net income growth 5Y	-10.64%
Net income growth years	2
OCF growth	7.73%
OCF growth (Q)	63.07%
OCF growth (QoQ)	37.06%
OCF growth 10Y	5.83%
OCF growth 3Y	9.82%
OCF growth 5Y	10.91%
Operating income growth	-1.53%
Operating income growth 3Y	5.7%
Operating income growth 5Y	13.81%
Revenue growth	4.64%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	1.97%
Revenue growth 10Y	5.37%
Revenue growth 3Y	4.51%
Revenue growth 5Y	8.68%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -3.4B
Depreciation and amortization	EUR 4.8B
EBIT	EUR 20.6B
EBITDA	EUR 25.3B
EPS	EUR 1.14
Financing cash flow	EUR 5.4B
Free cash flow	EUR 14.1B
Free cash flow minus SBC	EUR 13.3B
Gross profit	EUR 44.2B
Income taxes	EUR 2.4B
Investing cash flow	EUR -23.9B
Net borrowing	EUR 16.8B
Net cash flow	EUR -1B
Net income	EUR 2.8B
Operating cash flow minus SBC	EUR 16.7B
Operating income	EUR 20.6B
Revenue	EUR 58.3B
Stock-based compensation	EUR 780.8M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.6
Book value per share	EUR 14.87
Debt / EBITDA	1.84
Debt / equity	1.28
Debt / FCF	3.36
Goodwill	EUR 19.4B
Interest coverage	13.47
Long-term assets	EUR 80.7B
Long-term liabilities	EUR 52B
Net cash (debt)	EUR -40.9B
Net cash / market cap	-13.12%
Net debt / EBITDA	1.62
Net debt / equity	1.11
Net debt / FCF	2.91
Piotroski F-Score	4
Property, plant and equipment	EUR 23.1B
Shareholders' equity	EUR 36.7B
Tangible book value	EUR -4.1B
Tangible book value per share	EUR -1.64
Total assets	EUR 113.6B
Total cash	EUR 6.3B
Total debt	EUR 47.2B
Total liabilities	EUR 76.9B
WACC	4.98%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	EUR 32.9B
Current liabilities	EUR 24.9B
Current ratio	1.32
Inventory turnover	2.51
Net working capital	EUR 4.1B
Quick ratio	0.74
Working capital	EUR 7.8B
Working capital turnover	5.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.92%
Dividend growth	1.02%
Dividend growth (3Y)	2.58%
Dividend growth (5Y)	6.27%
Dividend growth years	0
Dividend payment date	2026-10-07
Dividend payment years	10
Dividend payout frequency	Quarterly
Dividend per share	EUR 2.94
Dividend yield	2.33%
Ex-dividend date	2026-09-15
Last dividend	EUR 0.74
Payout ratio	261.52%
Shareholder yield	4.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 112.75
1D price change	-1.22%
1M price change	-2.87%
1M total return	-2.87%
1W price change	-4.99%
1W total return	-4.99%
1Y price change	67.38%
1Y return CAGR	72.39%
1Y total return	72.33%
20-day SMA	EUR 129.32
200-day SMA	EUR 109.25
3M price change	8.64%
3M total return	9.28%
3Y price change	29.41%
3Y return CAGR	12.35%
3Y total return	41.83%
50-day SMA	EUR 128.65
50-day SMA vs 200-day SMA	50over200
52-week high	EUR 136.24
52-week high date	2026-10-22
52-week low	EUR 71.60
52-week low date	2025-11-04
5Y price change	79.06%
5Y return CAGR	15.85%
5Y total return	108.62%
6M price change	32.6%
6M total return	34.34%
All-time high	EUR 136.24
All-time high date	2026-10-22
All-time low	EUR 43.36
All-time low date	2018-04-04
Average true range (ATR)	EUR 3.06
Average volume	4.5
Beta (5Y)	0.22
Change from 52-week high	-7.49%
Change from 52-week low	76.03%
Change from all-time high	-7.49%
Change from all-time low	190.68%
Change from open	-0.36%
Day's gap	-0.86%
High price	EUR 127.24
Low price	EUR 126.04
Monthly RSI	67.58
Open price	EUR 126.50
Position in 52-week range	0%
Previous close	EUR 127.60
Price vs 150-day SMA	11.79%
Price vs 20-day SMA	-2.54%
Price vs 200-day SMA	15.37%
Price vs 50-day SMA	-2.03%
Relative volume	0.22
RSI	45.16
Sharpe ratio	1.74
Sharpe ratio (3Y)	0.41
Sharpe ratio (5Y)	0.55
Sortino ratio	3.19
Sortino ratio (3Y)	0.84
Sortino ratio (5Y)	1.04
Weekly RSI	59.29
YTD price change	39.27%
YTD total return	42.15%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.5B
Shares change (QoQ)	-0.08%
Shares change (YoY)	-1.92%
Shares held by insiders	0.05%
Shares held by institutions	81.22%
Short ratio	2.6 days

Deeper analysis on VIE/MRK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/MRK report

Is a complete VIE/MRK research report available?

No complete published report is available for vie/MRK (VIE/MRK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/MRK (VIE/MRK)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/MRK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/MRK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/MRK

Frequently asked questions